| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...861738C |
| P356 | DOI | 10.1371/JOURNAL.PONE.0061738 |
| P932 | PMC publication ID | 3631163 |
| P698 | PubMed publication ID | 23620788 |
| P5875 | ResearchGate publication ID | 236339807 |
| P50 | author | Bruce J Brew | Q61853479 |
| Caroline D. Rae | Q42420355 | ||
| Lucette Cysique | Q47825170 | ||
| P2093 | author name string | Andrew Carr | |
| Nicholas W S Davies | |||
| Danielle M Moore | |||
| Tammy A Lane | |||
| Kirsten Moffat | |||
| P2860 | cites work | Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort. | Q51910225 |
| The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. | Q51943315 | ||
| Neurocognitive dysfunction in the highly active antiretroviral therapy era. | Q37966773 | ||
| Longitudinal metabolic and cognitive changes in mild cognitive impairment patients | Q38389274 | ||
| Rapidly ageing HIV epidemic among men who have sex with men in Australia | Q38451585 | ||
| A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis | Q42441827 | ||
| Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. | Q42824364 | ||
| Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study | Q43279433 | ||
| Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. | Q44880209 | ||
| Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. | Q46396028 | ||
| Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. | Q46928817 | ||
| Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status | Q48610948 | ||
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study | Q24642517 | ||
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
| Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets | Q30879777 | ||
| A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging | Q31122588 | ||
| Improved method for accurate and efficient quantification of MRS data with use of prior knowledge | Q32172320 | ||
| Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) study | Q33532751 | ||
| Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction | Q33536778 | ||
| HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging | Q33583519 | ||
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study | Q33602915 | ||
| Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection | Q33933507 | ||
| Subclinical atherosclerosis is related to lower neuronal viability in middle-aged adults: a 1H MRS study | Q33976529 | ||
| Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research | Q34080236 | ||
| Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. | Q34125560 | ||
| Adjusting for multiple testing--when and how? | Q34215794 | ||
| Neuroimaging studies of the aging HIV-1-infected brain | Q34288457 | ||
| HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study | Q34370880 | ||
| Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment | Q35078313 | ||
| Brain creatine elevation and N-Acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of neuroAIDS | Q35116137 | ||
| Factors affecting brain structure in men with HIV disease in the post-HAART era. | Q35159533 | ||
| Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden | Q35164448 | ||
| Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging | Q36777939 | ||
| Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. | Q37393465 | ||
| Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study | Q37407266 | ||
| Pathogenesis of cardiovascular disease in HIV infection | Q37447632 | ||
| Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder | Q37966663 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e61738 | |
| P577 | publication date | 2013-04-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study | |
| P478 | volume | 8 |
| Q35276365 | APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study |
| Q37692750 | Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study |
| Q38628801 | An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge? |
| Q37226549 | CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease |
| Q41528498 | Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients |
| Q34324750 | Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity |
| Q36298436 | Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity |
| Q47193060 | Covertly active and progressing neurochemical abnormalities in suppressed HIV infection. |
| Q47104626 | Detecting Altered connectivity patterns in HIV associated neurocognitive impairment using Mutual Connectivity Analysis. |
| Q35568896 | Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART. |
| Q58595914 | Early Introduction of cART Reverses Brain Aging Pattern in Well-Controlled HIV Infection: A Comparative MR Spectroscopy Study |
| Q39527006 | Extracting patterns of morphometry distinguishing HIV associated neurodegeneration from mild cognitive impairment via group cardinality constrained classification |
| Q35867609 | Facial emotion recognition impairments are associated with brain volume abnormalities in individuals with HIV |
| Q28073408 | Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals |
| Q27025018 | HIV and aging: effects on the central nervous system |
| Q38223328 | HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. |
| Q35276630 | HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? |
| Q34721127 | HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research |
| Q33939729 | HIV-associated neurocognitive disorder. |
| Q37720509 | HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment. |
| Q27015965 | HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities |
| Q40294053 | HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients |
| Q35824849 | Imaging neuroinflammation? A perspective from MR spectroscopy. |
| Q40215978 | Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment |
| Q38767396 | Interventions for Neurocognitive Dysfunction |
| Q46135618 | Investigating Changes in Brain Network Properties in HIV-Associated Neurocognitive Disease (HAND) using Mutual Connectivity Analysis (MCA). |
| Q38973318 | Microvascular Function in Aging Among Women Living with HIV. |
| Q30854917 | Neuroimaging of HIV-associated neurocognitive disorders (HAND) |
| Q37205326 | Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children |
| Q36463660 | Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy |
| Q35582240 | Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy |
| Q33834306 | Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV. |
| Q26852705 | Role of neuroimaging in HIV-associated neurocognitive disorders |
| Q53075373 | The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity. |
| Q28066725 | The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review |
| Q45542483 | The Metamorphosis of HIV-Associated Neurocognitive Disorders |
| Q40486706 | The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study |
| Q91604272 | The joint effect of aging and HIV infection on microstructure of white matter bundles |
| Q90431804 | Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities |
| Q40413560 | Vocal emotion processing deficits in HIV-infected individuals |
| Q40282427 | White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration |
Search more.